ING5 and cancer: Zheng, “ING5‐Mediated Antineuroblastoma Effects of Suberoylanilide Hydroxamic Acid,” Cancer Medicine 7, no. 9 (2018): 4554–4569, https://doi.org/10.1002/cam4.1634.